Application of full-spectrum hyaluronic acid in the preparation of preparations for promoting laminin production
By using full-spectrum hyaluronic acid, specific polydispersion coefficient and molecular weight parameters, the shortcomings of hyaluronic acid in promoting skin laminin production are solved, and the significant laminin production effect is achieved, enhancing the structural support of the skin and Moisturizing function.
Patent Information
- Application Number
- CN202411045279.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-01
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-08-01
AI Technical Summary
The application of the single hyaluronic acid component in the prior art in promoting the production of skin laminin in the prior art is not effectively utilized, and effective compositions are lacking to significantly improve the production of collagen and laminin.
Full spectrum hyaluronic acid, specific polydispersion coefficient range (8-12) and molecular weight parameters (weight average molecular weight 800-1400kDa, number average molecular weight 90-130kDa) are used as preparations to promote laminin production, and are prepared by optimization The process and the amount of addition significantly improve the production of laminin.
The effect of the single hyaluronic acid component in promoting laminin production in the skin is achieved, especially when selecting appropriate polydispersion coefficient and molecular weight parameters, the surface percentage and production volume of laminin are significantly increased, and the skin is enhanced. Structural support and moisturizing functions.
Smart Images

Figure CN118593384B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of skin care products, and in particular relates to the application of full-spectrum hyaluronic acid in the preparation of a preparation for promoting the production of laminin. Background Art
[0002] The basement membrane of the skin is an important connecting structure between the epidermis and the dermis. Its main components include type IV and type WI collagen, laminin, entactin / nidogen, integrin, etc. The mesh structure formed by their cross-linking constitutes the rich and diverse biological functions of the basement membrane, mainly the epidermis-dermis connection function, signal transduction function and permeability barrier function. The basement membrane plays an important role in connecting the epidermis and the dermis. It is like a layer of double-sided tape, which closely connects the epidermis and the dermis. The networks formed by the aggregation of laminin 5 and type IV collagen contained in it intersect with each other, which plays a good structural support role for the epidermis and the dermis. Laminin (also known as laminin) is the most abundant non-collagen protein in the basement membrane, which is basically distributed in the transparent layer. Laminin 1, laminin 5 and laminin 6 are found in the basement membrane of the skin. Laminin 5 (α3β3γ2, also known as laminin 332) is located in the transparent plate of the basement membrane and is the main component of the anchoring fibrils. One end of it is connected to the integrin α6β4 on the transmembrane hemidesmosome, and the other end is connected to the type VII collagen in the anchoring fiber in the dermis, thus playing an important role in connecting the epidermis and dermis. The smooth circulation and communication between the epidermis, basement membrane and dermis is an important factor in the formation of healthy skin, which can be called the "golden cycle". With the increase of age, ultraviolet radiation and other factors, the basement membrane of the skin can overlap and break, and its connection and information transmission with the epidermis and dermis are hindered; the skin shows aging symptoms such as thinning of the epidermis, dryness of the epidermis, and reduced barrier function. Therefore, promoting the production of laminin and strengthening the connection between the epidermis and dermis plays an important role in slowing down the aging of the skin.
[0003] Hyaluronic acid (HA) is a high molecular mucopolysaccharide composed of N-acetylglucosamine and D-glucuronic acid disaccharide units repeatedly connected alternately. It is widely present in the human body and is an important component of the skin, vitreous body, synovial fluid and cartilage tissue. It has unique physical and chemical properties and biological functions. Due to its high viscoelasticity and plasticity, super strong water retention and permeability and good biocompatibility, it is widely used in the fields of food, cosmetics and medicine. In recent years, studies have found that the biological activity of HA is directly related to its relative molecular weight. HA of different molecular weights has different or even opposite biological activities. HA of high molecular weight fraction (average molecular weight of 1MDa-1.5MDa) provides excellent moisturizing properties for cosmetic compositions, while HA of low molecular weight fraction (average molecular weight of 20kDa-400kDa) shows anti-wrinkle properties because it can penetrate the skin barrier. In this field, "polydispersity (PD)" characterizes the width of the molecular weight distribution curve, which is calculated as the ratio of the weight average molecular weight Mw and the number average molecular weight Mn, that is, PD = Mw / Mn, where the number average molecular weight Mn is the total weight of all polymer molecules in the sample divided by the total number of molecules, and the weight average molecular weight Mw is the weight fraction of each molecule multiplied by its corresponding molecular weight, that is, the weight average molecular weight. Generally speaking, the larger the PD value, the wider the molecular weight distribution range. We define HA with a PD value ≥ 4.0 as full-spectrum hyaluronic acid.
[0004] Prior art CN 109844128 A discloses a laminin promoter, which uses an extract of at least one selected from brown algae, red algae and green algae or 1-(2-hydroxyethyl)-2-imidazolidinone as an effective ingredient. Prior art CN108992369B discloses a polypeptide composition for skin repair, which includes a polypeptide that promotes the production of skin laminin. Prior art CN116370348A discloses a composition, which can significantly improve the production of collagen and laminin by compounding dimethylaminoethanol tartrate with hyaluronic acid, and discloses that the expression level of laminin 5 protein is almost unaffected by the single component of sodium hyaluronate or the single component of dimethylaminoethanol tartrate or the compound of sodium hyaluronate and dimethylaminoethanol tartrate when the mass percentage is very small. There is no report on the application of hyaluronic acid as a single component in promoting laminin. Summary of the invention
[0005] The purpose of the present invention is to overcome the deficiencies of the above-mentioned prior art and provide a use of full-spectrum hyaluronic acid in the preparation of a preparation for promoting the production of laminin.
[0006] To achieve the above objectives, in a first aspect of the present invention, the present invention provides the use of full-spectrum hyaluronic acid in the preparation of a preparation for promoting the production of laminin.
[0007] The present invention has found that a single component of hyaluronic acid can also be effectively used to promote the production of laminin.
[0008] As a preferred embodiment of the application of the present invention, the laminin is laminin 5.
[0009] As a preferred embodiment of the application of the present invention, the polydispersity coefficient of the full-spectrum hyaluronic acid is 8-12.
[0010] The polydispersity coefficient (PD) characterizes the width of the molecular weight distribution curve and is calculated as the ratio of the weight average molecular weight to the number average molecular weight, that is, polydispersity coefficient = weight average molecular weight / number average molecular weight.
[0011] The present invention has found that the polydispersity coefficient of hyaluronic acid has a significant effect on the promotion of laminin production. When the polydispersity coefficient of hyaluronic acid is further selected to be in the range of 8-12, the effect is more significant.
[0012] Exemplarily, the polydispersity coefficient of the full-spectrum hyaluronic acid can be any point value or any two-point range value between 8-12, for example, it can be 8.0, 8.2, 8.4, 8.6, 8.8, 9.0, 9.2, 9.4, 9.6, 9.8, 10.0, 10.2, 10.4, 10.6, 10.8, 11.0, 11.2, 11.4, 11.6, 11.8, 12.0, etc.
[0013] As a preferred embodiment of the application of the present invention, the weight average molecular weight of the full-spectrum hyaluronic acid is 30-3000 kDa, the number average molecular weight is 20-150 kDa, the viscosity average molecular weight is 30-600 kDa, and the bulk density of the hyaluronic acid powder passing through an 80-mesh sieve is 0.160-0.230 g / cm 3 , the conductivity of the 0.5wt% hyaluronic acid aqueous solution is 800-900µs / cm.
[0014] The weight average molecular weight (Mw) is obtained by multiplying the weight fraction of each molecule by its corresponding molecular weight, that is, the statistical average molecular weight by weight; the number average molecular weight (Mn) is the total weight of all polymer molecules in the sample divided by the total number of molecules; the viscosity average molecular weight (Mv) is the average molecular weight measured by the solution viscosity method; the weight average molecular weight, number average molecular weight and viscosity average molecular weight can be measured by referring to the method in patent CN108992369B.
[0015] The testing method for the bulk density of the full-spectrum hyaluronic acid powder passing through an 80-mesh sieve is as follows: place a dry measuring cylinder on an electronic balance, add 1.0 g of the test sample by free fall, read the weight and volume of the test sample, and calculate the bulk density = weight / volume; the testing method for the conductivity of the 0.5wt% hyaluronic acid aqueous solution is as follows: take 0.5 g of the product, dissolve it in a 100mL volumetric flask, add 100mL of freshly boiled cold water to dissolve it, and detect the test solution according to the operating requirements of the conductivity meter.
[0016] The present invention has found that when the parameters of hyaluronic acid are further selected within the above range, the application effect of hyaluronic acid in promoting the production of laminin is more excellent.
[0017] For example, the weight average molecular weight of the full spectrum hyaluronic acid can be any point value or any two point range value between 30-3000 kDa, for example, 30 kDa, 50 kDa, 80 kDa, 100 kDa, 200 kDa, 300 kDa, 400 kDa, 500 kDa, 600 kDa, 700 kDa, 800 kDa, 900 kDa, 1000 kDa, 1100 kDa, 1200 kDa, 1300 kDa, 1400 kDa, 1500 kDa, 1600 kDa, 1700 kDa, 1800 kDa, 1900 kDa, 2000 kDa, 2100 kDa, 2200 kDa, 2300 kDa, 2400 kDa, 2500 kDa, 2600 kDa, 2700 kDa, 2800 kDa, 2900 kDa, 3000 kDa, 3100 kDa, 3200 kDa, 3300 kDa, 3400 kDa, 3500 kDa, 3600 kDa, 3700 kDa, 3800 kDa, 3900 kDa, 4000 kDa, 4100 kDa, 4200 kDa, 4300 kDa, 4400 kDa, 4500 kDa, 4600 kDa, 4700 kDa, 4800 kDa, 4900 kDa, 5100 kDa, 5 kDa, 1400 kDa, 1500 kDa, 1600 kDa, 1700 kDa, 1800 kDa, 1900 kDa, 2000 kDa, 2100 kDa, 2200 kDa, 2300 kDa, 2400 kDa, 2500 kDa, 2600 kDa, 2700 kDa, 2800 kDa, 2900 kDa, 3000 kDa, etc.; the number average molecular weight of the full spectrum hyaluronic acid may be 20- The viscosity-average molecular weight may be any point value or any two point range values between 30-600 kDa, for example, 30 kDa, 40 kDa, 50 kDa, 60 kDa, 70 kDa, 80 kDa, 90 kDa, 100 kDa, 110 kDa, 120 kDa, 130 kDa, 140 kDa, 150 kDa, etc.; the viscosity-average molecular weight may be any point value or any two point range values between 30-600 kDa, for example, 30 kDa , 50kDa, 80kDa, 100kDa, 120kDa, 150kDa, 180kDa, 200kDa, 220kDa, 250kDa, 280kDa, 300kDa, 320k Da, 350kDa, 380kDa, 400kDa, 420kDa, 450kDa, 480kDa, 500kDa, 520kDa, 550kDa, 580kDa, 600kDa, etc.
[0018] For example, the bulk density of the full-spectrum hyaluronic acid powder passing through an 80-mesh sieve is 0.160-0.230 g / cm 3Any point value or any range value between two points, for example, 0.160g / cm 3 、0.170g / cm 3 、0.180g / cm 3 、0.190g / cm 3 , 0.200g / cm 3 、0.210g / cm 3 , 0.220g / cm 3 , 0.230g / cm 3 etc.; the conductivity of the 0.5wt% full-spectrum hyaluronic acid aqueous solution can be any point value or any two-point range value between 800-900µs / cm, for example, 800µs / cm, 810µs / cm, 800µs / cm, 820µs / cm, 830µs / cm, 840µs / cm, 850µs / cm, 860µs / cm, 870µs / cm, 880µs / cm, 890µs / cm, 900µs / cm, etc.
[0019] As a preferred embodiment of the application of the present invention, the weight average molecular weight of the full-spectrum hyaluronic acid is 800-1400 kDa, and the number average molecular weight is 90-130 kDa.
[0020] The present invention has found that when the weight average molecular weight of the hyaluronic acid is further selected to be 800-1400 kDa and the number average molecular weight is 90-130 kDa, the obtained full-spectrum hyaluronic acid has a more significant promoting effect on the production of laminin.
[0021] Compared with the prior art, the present invention has the following beneficial effects:
[0022] The present invention provides the use of full-spectrum hyaluronic acid in the preparation of a preparation for promoting the production of laminin. The present invention has experimentally confirmed that a single full-spectrum hyaluronic acid with specific parameters can effectively promote the production of laminin in the skin. Therefore, the corresponding hyaluronic acid can be used as a component of a composition for promoting the production of laminin to achieve the effect of promoting the production of laminin. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 The present invention is a process flow chart of hyaluronic acid preparation;
[0024] Figure 2 It is a bar graph showing the percentage of the surface with positive immunostaining of basement membrane laminin 5 in effect example 2;
[0025] Figure 3 This is the result graph of laminin generation on the 7th day in the model group in effect example 2;
[0026] Figure 4Generate a result graph for the laminin on day 7 in effect example 2 using the blank product;
[0027] Figure 5 This is a graph showing the laminin generation results on the 7th day using the product of Example 1 in Effect Example 2;
[0028] Figure 6 This is a graph showing the results of laminin production on day 7 in Effect Example 2 using the product of Example 5. DETAILED DESCRIPTION
[0029] In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments.
[0030] Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art.
[0031] The hyaluronic acid used in the examples and comparative examples of the present invention is obtained by fermentation and purification of Streptococcus zooepidemicus (purchased from ATCC, catalog number HA-116ATCC39920);
[0032] The specific method for preparing hyaluronic acid 1 is as follows, and the preparation method flow chart is as follows Figure 1 As shown;
[0033] Culture medium
[0034] Slant culture medium (g / L): brain heart infusion (BHI) 36 g / L, glucose 12 g / L, yeast powder 12 g / L, agar powder 24 g / L, pH 7.2.
[0035] Seed culture medium (g / L): glucose 40 g / L, yeast powder 20 g / L, magnesium sulfate heptahydrate 2.0 g / L, manganese sulfate tetrahydrate 0.1 g / L, potassium dihydrogen phosphate 2.0 g / L, calcium carbonate 20 g / L, pH 7.0.
[0036] Fermentation medium (g / L): yeast powder 20 g / L, disodium hydrogen phosphate 6.2 g / L, potassium sulfate 1.3 g / L, glucose 140 g / L, magnesium sulfate heptahydrate 2.0 g / L, pH 7.0.
[0037] Cultivation methods
[0038] Slant culture: The inoculated slant was placed in a constant temperature incubator at 37±0.2℃ for 16±0.5h and used for shake flask inoculation.
[0039] Seed culture: inoculate the cultured slant seeds into a 500mL Erlenmeyer flask containing 50mL of seed culture medium, shake at 200r / min, temperature at 37±0.2℃, and culture time for 15h.
[0040] Fermentation culture: The seed culture medium was inoculated into a fully automatic fermenter KFT-7L (Biostat B2ndgeneration 1000009844, Sartorius, Germany) at a 10% inoculation rate, and the fermentation medium was 3.5L in the tank. The stirring speed was 200±10r / min, the ventilation volume was 1.0vvm, and the temperature was 37±0.2℃. The pH was detected online using a pH electrode, and 5mol / LNaOH solution was added by an automatic feed pump to adjust the pH to maintain the pH change within 7.0±0.1. The dissolved oxygen concentration was detected online using a dissolved oxygen electrode, and samples were taken every 2h for detection and analysis.
[0041] Extraction and purification
[0042] Take an appropriate amount of fermentation liquid, place it in a stainless steel tank (the discharge port is connected to a plate and frame filter), add water, adjust to a concentration of about 0.5%, stir the mixed liquid, stir at a speed of 200±10r / min, the temperature is 60℃, mix for about 30 minutes, after mixing evenly, add 6mol / L HCl to adjust the pH to 2.4, continue stirring at this temperature for 3h, then start to discharge the liquid, the discharge time lasts for 6h, and keep stirring in the tank during the discharge. After discharging and filtering until the transmittance of the filtrate reaches 99.9% (550nm), a mixed filtrate 1 is obtained, placed in a stainless tank, and 5mol / L NaOH is slowly added to adjust the pH to 7, keep stirring, and stir at a speed of 200±10r / min to obtain a mixed filtrate 2. Take the mixed filtrate 2, add 70% ethanol to precipitate, keep stirring, and stir at a speed of 50±5r / min to obtain a mixed liquid 3. Take the mixed liquid 3, centrifuge it for 1 hour at a speed of 4000r / min, discard the supernatant, take the lower layer of sediment, dry it, turn the plate every 2 hours, take a dry sample to determine the drying loss, dry it to constant weight, crush it, pass it through an 80-mesh sieve, and obtain the product.
[0043] The parameters of hyaluronic acid 1 are: Mw=852 kDa, Mn=105 kDa, Mη=325 kDa, PD=8.11, and the bulk density of the powder passing through an 80-mesh sieve is 0.19 g / cm 3 , the conductivity of 0.5wt% hyaluronic acid aqueous solution is 856µs / cm.
[0044] The only difference between the preparation method of hyaluronic acid 2 and hyaluronic acid 1 is that after adding 6 mol / L HCl to adjust the pH to 2.5, stirring is continued at this temperature for 3 h, and then the feed liquid is discharged, and the discharge time lasts for 9 h; the parameters of the prepared hyaluronic acid 2 are: Mw=1120 kDa, Mn=94.1 kDa, Mη=453 kDa, PD=11.90, and the bulk density of the powder passing through an 80-mesh sieve is 0.20 g / cm 3 , the conductivity of 0.5wt% hyaluronic acid aqueous solution is 870µs / cm.
[0045] The only difference between the preparation method of hyaluronic acid 3 and hyaluronic acid 1 is that after adding 6 mol / L HCl to adjust the pH to 2.7, stirring is continued at this temperature for 2 hours, and then the feed liquid is discharged, and the discharge time lasts for 9 hours; the parameters of the prepared hyaluronic acid 3 are: Mw=1618 kDa, Mn=140 kDa, Mη=580 kDa, PD=11.56, and the bulk density of the powder passing through an 80-mesh sieve is 0.18 g / cm 3 , the conductivity of 0.5wt% hyaluronic acid aqueous solution is 865µs / cm.
[0046] The only difference between the preparation method of hyaluronic acid 4 and hyaluronic acid 1 is that after adding 6 mol / L HCl to adjust the pH to 2.2, stirring is continued at this temperature for 4 h, and then the feed liquid is discharged, and the discharge time lasts for 9 h; the parameters of the prepared hyaluronic acid 4 are: Mw=730 kDa, Mn=72 kDa, Mη=320 kDa, PD=10.13, and the bulk density of the powder passing through an 80-mesh sieve is 0.19 g / cm 3 , the conductivity of 0.5wt% hyaluronic acid aqueous solution is 868µs / cm.
[0047] The only difference between the preparation method of hyaluronic acid 5 and hyaluronic acid 1 is that after adding 6 mol / L HCl to adjust the pH to 2.4, stirring is continued at this temperature for 3 h, and then the feed liquid is discharged, and the discharge time lasts for 5 h; the parameters of the prepared hyaluronic acid 5 are: Mw=890 kDa, Mn=123 kDa, Mη=485 kDa, PD=7.24, and the bulk density of the powder passing through an 80-mesh sieve is 0.20 g / cm 3 , the conductivity of 0.5wt% hyaluronic acid aqueous solution is 870µs / cm.
[0048] The only difference between the preparation method of hyaluronic acid 6 and hyaluronic acid 1 is that after adding 6 mol / L HCl to adjust the pH to 2.6, stirring is continued at this temperature for 3 hours, and then the feed liquid is discharged, and the discharge time lasts for 10 hours; the parameters of the prepared hyaluronic acid 6 are: Mw=1360 kDa, Mn=105 kDa, Mη=510 kDa, PD=12.95, and the bulk density of the powder passing through an 80-mesh sieve is 0.17 g / cm 3 , the conductivity of 0.5wt% hyaluronic acid aqueous solution is 854µs / cm.
[0049] Test example
[0050] The test example of the present invention provides a skin care composition, and the components (mass percentage) of the skin care composition are shown in Table 1;
[0051] Table 1
[0052]
[0053] The preparation method of the skin care composition is:
[0054] (1) Weigh phase B and heat to 80±2℃, stirring until completely dissolved;
[0055] (2) Weigh phase A, heat to 80±2℃, and stir evenly;
[0056] (3) Slowly add phase A to phase B, stirring while adding, and homogenize until uniform;
[0057] (4) Stir and cool down. When the temperature is below 50℃ (45±2℃), add phase C and stir until uniform.
[0058] (5) Cooling, aging, and filling.
[0059] Effect Example 1
[0060] The effect example of the present invention verifies the transdermal permeability of hyaluronic acid 1-6, which specifically includes the following steps:
[0061] Use sterile tweezers to transfer the in vitro reconstructed 3D skin model (from Guangzhou Ruby Biotechnology Co., Ltd.) to a 6-well plate pre-filled with serum-free culture medium and place it in a CO2 cell culture incubator at 5% CO2, 37°C, and 95% saturated humidity for 1 hour. Replace each well with fresh serum-free culture medium (0.9 mL / well) and continue to culture in a CO2 cell culture incubator (5% CO2, 37°C, 95% saturated humidity) for 20 hours. Fresh serum-free culture medium (0.9 mL / well) was replaced for each well, and 60 µL of test solution was added to the in vitro reconstructed 3D skin model (the test solution included: test solution 1-6 was hyaluronic acid 1-6 aqueous solution with a mass concentration of 0.5%, test solution 7 was hyaluronic acid 1 aqueous solution with a mass concentration of 0.1%, and test solution 8 was hyaluronic acid 1 aqueous solution with a mass concentration of 0.8%). 60 µL of phosphate buffer solution was added to the blank group and placed in a CO2 cell culture incubator (5% CO2, 37°C, 95% saturated humidity) for further incubation for 24 h. The content of hyaluronic acid in the solution of the 6-well plate was measured using a human hyaluronic acid enzyme-linked immunosorbent assay kit (from Nanjing Herb Source Biotechnology Co., Ltd.), and the permeability was calculated. The permeability was calculated as follows: permeability = the content of hyaluronic acid in the solution of the 6-well plate measured using a human hyaluronic acid enzyme-linked immunosorbent assay kit / the content of the test solution × 100%;
[0062] The results obtained are shown in Table 2;
[0063] Table 2
[0064]
[0065] As can be seen from Table 2, the hyaluronic acid provided by the present invention has excellent permeability, especially when the added amount of hyaluronic acid is 0.5wt%, the permeability is above 8.89%, and especially when the weight average molecular weight of the hyaluronic acid is further selected to be 800-1400kDa, the number average molecular weight is 90-130kDa, and the dispersion coefficient is 8-12, the obtained permeability is above 9.18%.
[0066] Effect Example 2
[0067] The effect examples of the present invention verify the promoting effect of the skin care compositions of Examples 1-6, Comparative Examples 1-2 and the blank example on the production of laminin in the basal layer of the skin, and specifically include the following steps:
[0068] A certain amount of the skin care composition of Examples 1-6, Comparative Examples 1-2 and the blank example was respectively applied evenly on the prepared human ex vivo skin surface on the 0th day, the 2nd day, the 5th day and the 6th day until all the skin was absorbed (the ratio of the amount applied to the applied area of Examples 1-6, Comparative Examples 1-2 and the blank example was consistent, which was 0.020-0.025 g / cm 2The ex vivo human skin was obtained from the abdominal ex vivo skin of a 56-year-old Caucasian female. The skin was sliced into 5 µm thick sections using a Leica RM 2125 Minot-type microtome. The tissue was immunostained on the 7th day. The staining was observed and evaluated using a Leica DMLB microscope. The image analysis software CellSens (Olympus) was then used for semi-quantitative analysis to calculate the percentage of the surface with positive laminin 5 immunostaining along the basement membrane. The results are shown in Table 3. The data are expressed as mean ± SEM. The statistical analysis results above the error bars are reported as follows: * p < 0.05; ** p < 0.01; *** p < 0.001. The statistical analysis within the group (compared with the model group) is indicated by a black asterisk, and the statistical analysis between the groups (compared with the blank case) is indicated by a "#". The model group refers to the ex vivo human skin without any treatment.
[0069] Table 3
[0070]
[0071] The data in Table 3 are presented in the form of a bar graph, as shown in Figure 2 As shown in Table 3 and Figure 2 It can be clearly seen that the hyaluronic acid provided by the present invention can effectively promote the production of laminin, especially when added in an amount of 0.5wt%, the surface percentage of laminin 5 after use is significantly different from that of the blank case and the model group; in particular, when the weight average molecular weight of the hyaluronic acid is further selected to be 800-1400kDa, the number average molecular weight is 90-130kDa, and the polydispersity coefficient is 8-12, the surface percentage of laminin 5 after use is above 34.8%.
[0072] In addition, on the 7th day, the model group, the blank example, the example 1 and the example 5 were stained, and microscopic observation was performed using a LeicaDMLB microscope. The images were digitized using a digital DP74 Olympus camera and cellSens storage software (Olympus). The image results obtained for the model group, the blank example, the example 1 and the example 5 are shown as follows: Figure 3-6 shown; from Figure 3-6 It can also be seen intuitively that compared with the blank case and the model group, the laminin content (green fluorescence area, the more obvious and clear the green fluorescence, the more laminin 5 is produced) is higher in the technical solution of the present invention, that is, the hyaluronic acid provided by the present invention can significantly promote the production of laminin.
[0073] Finally, it should be noted that the above embodiments are intended to illustrate the technical solution of the present invention rather than to limit the scope of protection of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention may be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.
Claims
1. Use of full-spectrum hyaluronic acid in the preparation of a preparation for promoting laminin production; the polydispersity coefficient of the full-spectrum hyaluronic acid is 8-12; The laminin is laminin 5; The weight average molecular weight of the full-spectrum hyaluronic acid is 800-1400 kDa, the number average molecular weight is 90-130 kDa, the viscosity average molecular weight is 30-600 kDa, and the bulk density of the powder of the full-spectrum hyaluronic acid through an 80-mesh sieve is 0.160-0.230 g / cm 3 , the conductivity of the 0.5wt% full-spectrum hyaluronic acid aqueous solution is 800-900µs / cm; In the preparation for promoting laminin production, the added amount of full-spectrum hyaluronic acid is 0.5wt%.
Citation Information
Patent Citations
A type of hyaluronic acid, its preparation method and uses
CN108992369B
Laminin 511 production promoter, basal epidermal layer stabilizer and / or screening method for agent to minimize reduction in or promote increase in epidermal stem cells
CN109844128A
Tightening composition and application thereof
CN116370348A
Hyaluronic acid as well as preparation method and application thereof
CN108992369A
